BioVie Inc.
BIVI
$1.97
-$0.10-4.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -0.72% | -1.25% | -11.50% | -2.14% | -3.13% |
| Depreciation & Amortization | -22.25% | 0.00% | 0.00% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.38% | 7.30% | -23.98% | -24.37% | -43.86% |
| Operating Income | -25.38% | -7.30% | 23.98% | 24.37% | 43.86% |
| Income Before Tax | -25.83% | -4.86% | 28.17% | 27.71% | 45.39% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -25.83% | -4.86% | 28.17% | 27.71% | 45.39% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.83% | -4.86% | 28.17% | 27.71% | 45.39% |
| EBIT | -25.38% | -7.30% | 23.98% | 24.37% | 43.86% |
| EBITDA | -25.99% | -7.39% | 24.21% | 24.60% | 44.17% |
| EPS Basic | 78.83% | 79.53% | 87.04% | 84.37% | 81.15% |
| Normalized Basic EPS | 78.10% | 79.04% | 86.18% | 83.72% | 81.36% |
| EPS Diluted | 78.81% | 79.52% | 87.03% | 84.37% | 81.16% |
| Normalized Diluted EPS | 78.10% | 79.04% | 86.18% | 83.72% | 81.36% |
| Average Basic Shares Outstanding | 383.12% | 382.24% | 414.99% | 404.38% | 227.43% |
| Average Diluted Shares Outstanding | 383.12% | 382.24% | 414.99% | 404.38% | 227.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |